Plain-English translation of NCT07793461 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Parkinson's Disease research guide โPhase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Researchers want to understand how your stomach breaks down levodopa, a common Parkinson's medication. Some people's stomachs may process this medication differently than others, and this study will investigate whether certain stomach cells affect how well the medication works for you.
Levodopa helps many people with Parkinson's disease, but it doesn't work the same way for everyone. By studying how different stomachs process this medication, researchers hope to eventually predict who will benefit most from it and improve treatment for all Parkinson's patients.
You'll visit the research center for one study day. You'll skip breakfast and your regular Parkinson's medications that morning. At the visit, you'll have a quick neurological exam, then take a single dose of levodopa by mouth. Over the next 4 hours, researchers will draw blood samples every 30 minutes (using a small tube in your arm so they don't have to poke you repeatedly) and repeat brief exams to see how the medication affects your symptoms. Afterward, you can eat and resume your normal medications. Separately, researchers will also examine a stomach tissue sample that was already removed during your previous medical care.
AI-generated summary from trial data ยท Aug 28, 2026 ยท Not medical advice
United States